Pharvaris (PHVS) had the highest return between December 7, 2022 and January 10, 2023 by a mid-cap US stock, returning 361.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Pharvaris (PHVS) | 12/7/2022 - 1/10/2023 | 361.67% |
Soleno Therapeutics (SLNO) | 12/7/2022 - 1/10/2023 | 151.55% |
Viking Therapeutics (VKTX) | 12/7/2022 - 1/10/2023 | 144.89% |
Sotera Health (SHC) | 12/7/2022 - 1/10/2023 | 107.33% |
TAL Education (TAL) | 12/7/2022 - 1/10/2023 | 73.36% |
Arcellx (ACLX) | 12/7/2022 - 1/10/2023 | 63.42% |
Aurinia Pharmaceuticals (AUPH) | 12/7/2022 - 1/10/2023 | 62.61% |
Kingsoft Cloud Holdings (KC) | 12/7/2022 - 1/10/2023 | 55.23% |
Grupo Financiero Galicia SA ADR (GGAL) | 12/7/2022 - 1/10/2023 | 52.37% |
Protagonist Therapeutics (PTGX) | 12/7/2022 - 1/10/2023 | 52.33% |
Terns Pharmaceuticals (TERN) | 12/7/2022 - 1/10/2023 | 49.75% |
BBVA Banco Frances SA ADR (BBAR) | 12/7/2022 - 1/10/2023 | 47.51% |
TG Therapeutics (TGTX) | 12/7/2022 - 1/10/2023 | 45.95% |
New Oriental Education & Technology (EDU) | 12/7/2022 - 1/10/2023 | 43.09% |
Melco Resorts & Entertainment (MLCO) | 12/7/2022 - 1/10/2023 | 42.9% |
Bitfarms (KEEL) | 12/7/2022 - 1/10/2023 | 42.72% |
POET Technologies (POET) | 12/7/2022 - 1/10/2023 | 41.36% |
Eos Energy Enterprises (EOSE) | 12/7/2022 - 1/10/2023 | 40.19% |
Bilibili (BILI) | 12/7/2022 - 1/10/2023 | 40.09% |
GDS (GDS) | 12/7/2022 - 1/10/2023 | 39.63% |
Atour Lifestyle Holdings Limited American Depositary Shares (ATAT) | 12/7/2022 - 1/10/2023 | 38.88% |
Banco Macro SA B ADR (BMA) | 12/7/2022 - 1/10/2023 | 38.32% |
DocuSign (DOCU) | 12/7/2022 - 1/10/2023 | 38.28% |
Praxis Precision Medicines (PRAX) | 12/7/2022 - 1/10/2023 | 38.28% |
Transocean (RIG) | 12/7/2022 - 1/10/2023 | 38.21% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.